Quest Diagnostics Incorporated
Mark E Delaney (SVP & Chief Commercial Officer) reports DGX insider transactions
AI-generated summary
Mark E Delaney, SVP & Chief Commercial Officer of Quest Diagnostics Incorporated, received 2,615 shares as a grant on November 3, 2026. Following this transaction, the insider directly holds 12,975 shares.
Key facts
- Insider
- Mark E Delaney · SVP & Chief Commercial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | A · grantFootnotes F1 | +2,615 | $0.00 | $0.00 | 12,975 | Direct |
Footnotes
- F1 Represents an award of restricted stock units.
More DGX filings
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 3
Filed Nov 5, 2026
- 144
Filed Nov 3, 2026
- 4
Filed Oct 28, 2026
- 144
Filed Oct 26, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.